News
- Lab Recieves New NIH/NCI R21
- Lab awarded new NIH/ NIDCR R03 grant
- Early kinetics of ctHPVDNA following surgery for HPV+OPSCC could serve as a biomarker for selecting adjuvant treatment
- Dipon Das, PhD and Vasileios Efthymiou, MD join the Faden Lab
- HPV-associated head and neck cancer blood test shows promise as a test to replace tissue biopsy
- HPV vaccination program feature
- Trio of manuscripts from the Faden Lab described the clinical, genomic and viromic landscape of patients with multiple HPV+ head and neck cancers
- Human Papillomavirus in Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
- Faden Lab Receives NIH Funding
- Head and Neck Cancer Stereotactic RadioSurgery Program
Gallery
Twitter Feed
-
@HNSurgeon @TopfHNS @JohnSunwooMD @DrJohndeAlmeida @JamesBatesMD @DrTonyEskander @NikkiSchmittMD @TassoneHNS @HNCancerDoc @NaverisDx Thanks @HNSurgeon for the shout-out. I'll expand on that line by saying, for me, 2022 was the year medicine began to realize the true potential of ctDNA. Critical works in Colorectal, Lung and Breast led the way, but important advancements in HPV+HNSCC as well, from many groups
-
t.co/tbmToKioDm
-
t.co/n73UUpWhog
-
Congrats to our lab's @saskianaegele for this important work. Proud of her contributions here, with more to come. @MGHPathology @PathDocBoston @ScarlessThyroid t.co/dJLelO4w99
-
@jillianmcwise @harvardmed Congrats Jillian! Well deserved.
